HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.

Abstract
Nucleocytoplasmic transport is dysregulated in sporadic and familial amyotrophic lateral sclerosis (ALS) and retinal ganglion neurons (RGNs) are purportedly involved in ALS. The Ran-binding protein 2 (Ranbp2) controls rate-limiting steps of nucleocytoplasmic transport. Mice with Ranbp2 loss in Thy1+-motoneurons develop cardinal ALS-like motor traits, but the impairments in RGNs and the degree of dysfunctional consonance between RGNs and motoneurons caused by Ranbp2 loss are unknown. This will help to understand the role of nucleocytoplasmic transport in the differential vulnerability of neuronal cell types to ALS and to uncover non-motor endophenotypes with pathognomonic signs of ALS. Here, we ascertain Ranbp2's function and endophenotypes in RGNs of an ALS-like mouse model lacking Ranbp2 in motoneurons and RGNs. Thy1+-RGNs lacking Ranbp2 shared with motoneurons the dysregulation of nucleocytoplasmic transport. RGN abnormalities were comprised morphologically by soma hypertrophy and optic nerve axonopathy and physiologically by a delay of the visual pathway's evoked potentials. Whole-transcriptome analysis showed restricted transcriptional changes in optic nerves that were distinct from those found in sciatic nerves. Specifically, the level and nucleocytoplasmic partition of the anti-apoptotic and novel substrate of Ranbp2, Pttg1/securin, were dysregulated. Further, acetyl-CoA carboxylase 1, which modulates de novo synthesis of fatty acids and T-cell immunity, showed the highest up-regulation (35-fold). This effect was reflected by the activation of ramified CD11b+ and CD45+-microglia, increase of F4\80+-microglia and a shift from pseudopodial/lamellipodial to amoeboidal F4\80+-microglia intermingled between RGNs of naive mice. Further, there was the intracellular sequestration in RGNs of metalloproteinase-28, which regulates macrophage recruitment and polarization in inflammation. Hence, Ranbp2 genetic insults in RGNs and motoneurons trigger distinct paracrine signaling likely by the dysregulation of nucleocytoplasmic transport of neuronal-type selective substrates. Immune-modulators underpinning RGN-to-microglial signaling are regulated by Ranbp2, and this neuronal-glial system manifests endophenotypes that are likely useful in the prognosis and diagnosis of motoneuron diseases, such as ALS.
AuthorsKyoung-In Cho, Dosuk Yoon, Minzhong Yu, Neal S Peachey, Paulo A Ferreira
JournalCellular and molecular life sciences : CMLS (Cell Mol Life Sci) Vol. 76 Issue 17 Pg. 3407-3432 (Sep 2019) ISSN: 1420-9071 [Electronic] Switzerland
PMID30944974 (Publication Type: Journal Article)
Chemical References
  • Molecular Chaperones
  • Nuclear Pore Complex Proteins
  • Thy-1 Antigens
  • ran-binding protein 2
  • Tamoxifen
  • Matrix Metalloproteinases, Secreted
  • Mmp28 protein, mouse
  • ACC1 protein, mouse
  • Acetyl-CoA Carboxylase
Topics
  • Acetyl-CoA Carboxylase (genetics, metabolism)
  • Active Transport, Cell Nucleus
  • Amyotrophic Lateral Sclerosis (metabolism, pathology)
  • Animals
  • Disease Models, Animal
  • Evoked Potentials (drug effects)
  • Gene Expression Regulation
  • Lipid Metabolism
  • Matrix Metalloproteinases, Secreted (genetics, metabolism)
  • Mice
  • Mice, Knockout
  • Microglia (metabolism)
  • Molecular Chaperones (genetics, metabolism)
  • Motor Neurons (metabolism)
  • Nuclear Pore Complex Proteins (deficiency, genetics, metabolism)
  • Optic Nerve (abnormalities, pathology)
  • Paracrine Communication
  • Retinal Ganglion Cells (metabolism)
  • Tamoxifen (pharmacology)
  • Thy-1 Antigens (genetics, metabolism)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: